| Jillian Ashley Mcelmurry-dobin, PHARMD | |
|
7975 E Us Highway 36, Avon, IN 46123-7975 | |
| (317) 272-5563 | |
| (317) 272-7061 |
| Full Name | Jillian Ashley Mcelmurry-dobin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7975 E Us Highway 36, Avon, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144503830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26023638A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jillian Ashley Mcelmurry-dobin, PHARMD 7975 E Us Highway 36, Avon, IN 46123-7975 Ph: (317) 272-5563 | Jillian Ashley Mcelmurry-dobin, PHARMD 7975 E Us Highway 36, Avon, IN 46123-7975 Ph: (317) 272-5563 |
News Archive
A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression. This new development represents a big step forward in personalized medicine.
Alarm over high lead contamination of Esperance sea food. The presence of high concentrations of lead found in fish in a part of Western Australia has prompted a warning to people living in the Esperance area to avoid eating some local seafood.
Women with coronary artery disease that reduces blood flow and oxygen to the heart muscle (ischemia) have significantly more chest pain caused by plaque build-up, yet less extensive disease as compared with men, according to new research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) today disclosed the results of its previously announced rights offering. The Company will raise an aggregate of C$9,687,233 from the rights offering and issue a total of 52,363,419 common shares at a price of C$0.185 per share (the "Subscription Price").
Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.
› Verified 7 days ago
Ms. Leslie Deann Wells, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 Fax: 317-272-5061 | |
Ms. Angela Marie Swiezy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7990 E Us Highway 36, Avon, IN 46123 Phone: 317-272-0242 | |
Julie Kippenbrock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7975 E Us Highway 36, Avon, IN 46123 Phone: 317-272-5563 | |
Dr. Beverly Rachel Bortz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 | |
David Errett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9500 E Us Highway 36, Avon, IN 46123 Phone: 317-209-8204 | |
Mrs. Kara Anne Appell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10209 E Us Highway 36, Avon, IN 46123 Phone: 317-271-6598 |